Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (27 ops.)
Latest filing published 05 Oct 2026 for Tango Therapeutics, Inc., €124k.
Filing timeline
BuySaleAdam Crystal
Insider track record
Disclosed buys
0
Disclosed sells
27
Signal history
Adam Crystal: trading record in brief
Adam Crystal has 48 filings published from April 6, 2021 to October 5, 2026, at Tango Therapeutics, Inc. (27, under the title President, R&D) and C4 Therapeutics, Inc. (21, as Chief Medical Officer). Volume is concentrated in 2021 (14 filings) and 2026 (19), against 3 in 2024 and 2025.
The 27 open-market sales total EUR 7,035,649, with a median of EUR 203,120. The three largest, all at Tango, date from April 15, 2026 (EUR 814,198), February 25, 2026 (EUR 589,550) and October 1, 2026 (EUR 569,487). No purchase is on record. The record also holds 15 option exercises and 6 share grants.
Over the last twelve months, 19 filings are recorded, 12 of them sales. They are published a median of 2 days after the trade.
At Tango, Barbara Weber and Daniella Beckman each have 8 trades within 30 days of Crystal's; at C4, Malcolm Salter has 8, Elena Prokupets and Jolie Siegel 6 each, always in the same direction.
Companies and markets linked to Adam Crystal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations48 total
27,000 shares@ US$5.200.0036% mcap2.6% of flowCommon StockSEC:0001193125-26-414500:0
26,400 shares@ US$24.45470.016% mcap12.0% of flowCommon StockSEC:0001193125-26-414500:1
600 shares@ US$25.320.0004% mcap0.3% of flowCommon StockSEC:0001193125-26-414500:2
27,000 shares@ US$5.200.0033% mcap3.0% of flowCommon StockSEC:0001193125-26-381853:0
27,000 shares@ US$22.3670.014% mcap12.9% of flowCommon StockSEC:0001193125-26-381853:1
27,000 shares@ US$5.200.0034% mcap3.0% of flowCommon StockSEC:0001193125-26-335002:0
5,267 shares@ US$26.78950.0034% mcap3.0% of flowCommon StockSEC:0001193125-26-335002:1
21,733 shares@ US$27.35090.014% mcap12.8% of flowCommon StockSEC:0001193125-26-335002:2
38,460 shares@ US$5.200.0040% mcap4.2% of flowCommon StockSEC:0001193125-26-159747:0
38,460 shares@ US$25.000.019% mcap20.2% of flowCommon StockSEC:0001193125-26-159747:1
27,000 shares@ US$5.203.0% of flowCommon StockSEC:0001193125-26-140874:0
27,000 shares@ US$21.202912.2% of flowCommon StockSEC:0001193125-26-140874:1
12,000 shares@ US$20.114.0% of flowCommon StockSEC:0001193125-26-129990:1
12,000 shares@ US$5.201.3% of flowCommon StockSEC:0001193125-26-129990:0
20,251 shares@ US$15.006.5% of flowCommon StockSEC:0001193125-26-098443:0
54,345 shares@ US$12.774114.6% of flowCommon StockSEC:0001193125-26-083579:0
18,251 shares@ US$12.263.6% of flowCommon StockSEC:0001193125-26-038052:1
201 shares@ US$12.900.0% of flowCommon StockSEC:0001193125-26-038052:2
47,460 shares0Common StockSEC:0001193125-26-038052:0
6,851 shares@ US$3.160.4% of flowCommon StockSEC:0000950170-25-015693:1
7,432 shares@ US$2.9880.5% of flowCommon StockSEC:0000950170-25-015693:0
53,015 shares0Common StockSEC:0000950170-25-014813:0
4,083 shares@ US$12.620.9% of flowCommon StockSEC:0000950170-24-012991:1
4,288 shares@ US$12.56261.2% of flowCommon StockSEC:0000950170-24-012991:0
46,599 shares0Common StockSEC:0000950170-24-011257:0
25 of 48 declarations
